Application of group of serum metabolic markers in predicting individual efficacy of warfarin and guiding individualized medication of warfarin

A metabolic marker, serum technology, applied in biological testing, biochemical equipment and methods, and microbial determination/examination, etc., can solve problems such as hidden dangers of outpatient follow-up rate, and achieve the effect of improved prediction accuracy and high reliability

Active Publication Date: 2020-11-24
江苏省食品药品监督检验研究院
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are great hidden dangers in the rate of follow-up visits after discharge and whether p

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of group of serum metabolic markers in predicting individual efficacy of warfarin and guiding individualized medication of warfarin
  • Application of group of serum metabolic markers in predicting individual efficacy of warfarin and guiding individualized medication of warfarin
  • Application of group of serum metabolic markers in predicting individual efficacy of warfarin and guiding individualized medication of warfarin

Examples

Experimental program
Comparison scheme
Effect test
No Example Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses application of a group of serum metabolic markers in predicting individual efficacy of warfarin and guiding individualized medication of the warfarin. It is found that the prediction accuracy of different drug effect samples of warfarin is significantly improved by combining serum metabolic markers guanosine, uridine, fumaric acid and thromboxine B2 with traditional indexesVKORC1 genotype, weight, serum creatinine and amiodarone for drug combination. Therefore, the group of serum metabolic markers can be used for predicting the individual efficacy of warfarin or guiding the individualized medication of warfarin in combination with the traditional indexes, and can be prepared into a kit for predicting the individual efficacy of warfarin or guiding the individualizedmedication of warfarin in combination with the traditional indexes.

Description

technical field [0001] The invention belongs to the field of biochemistry and relates to the application of markers in the guidance of clinical medication, in particular to the application of a group of serum metabolic markers in predicting the efficacy of individual warfarin and guiding warfarin individualized medication. Background technique [0002] Warfarin (warfarin) is the most commonly used anticoagulant in the prevention and treatment of vascular embolism diseases in the world. Cardiac surgery patients usually need long-term or life-long treatment. Warfarin is also one of the drugs responsible for the most serious adverse events due to its very narrow therapeutic window and high inter-individual variability in drug response. In clinical practice, in order to make warfarin's anticoagulant efficacy index INR (International Normalized Ratio) reach the therapeutic window, the dose of warfarin used by different patients varies by more than 10 times. If the anticoagulant ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N30/02G01N30/06G01N30/34G01N30/36G01N30/72G01N30/88G01N33/70C12Q1/6883
CPCG01N30/02G01N30/36G01N30/06G01N30/34G01N30/7266G01N30/88G01N33/70C12Q1/6883G01N2030/8822G01N2800/226C12Q2600/106C12Q2600/156
Inventor 黄青曹玲樊夏雷谭力钱翰宇罗楠施海蔚马跃新张莹刘书娟
Owner 江苏省食品药品监督检验研究院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products